NHINational Health Investors, Inc.

$67.09-6.6% 1Y

$67.09

$63.9852 weeks$90.00

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 19.4 vs a 15.3 median over 41 quarters (+27% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

National Health Investors, Inc. trades at 19.4× earnings against 38.9× for the median REIT - Healthcare Facilities name, cheaper than its own group.

19.4

Trailing P/E · REIT - Healthcare Facilities median 38.9 · cheaper than the typical name in its group

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $3.46 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$42.32
Its own P/E history, median	$52.77
Its own P/E history, upper quartile	$74.61
52-week range	$63.98 – $90.00
Today	$67.09

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.

The closest names by size in the same industry